Identified risks to pricing and market access in global markets for related and non-related therapeutic areas
CRA Approach
- Developed a framework that captures the likely impact of COVID-19 on major markets
- Examine market’s potential policy response, driven by the economic crisis, the need to invest in health and how these measures might impact medicines
- Set out an assessment for Client including:
- The policy changes likely to have the biggest impact
- Divergence from past approaches that will require a renewed focus for company advocacy and business planning
- Suggest indicator triggers and/or metrics for prospective monitoring
Client Impact
- Developed a unique framework to analyse the potential impact of COVID-19 and drivers of policy change in P&R landscape
- Provided market-based dashboard assessment of scenarios with likelihood and magnitude of impact of COVID-19 on Client portfolio. Identified any potential risks and opportunities to business
- Moderated discussion to identify implications and mitigation strategies for Client to respond to COVID-19
